Dr. Eleftherios Georgakopoulos has directed Acrogenomics Inc, which is listed on the New York Stock Exchange, and is one of the largest companies in the world in genetics and nanotechnology. The company’s research program aim was at developing nanoparticles and identifying their properties for use in clinical applications. 

During his scientific career, he founded and organized the Molecular Biology and Genetics Unit at the Athens Medical Center, where he developed and executed 5 research programs, in epithelial type cancer and the possibility of early diagnosis of micrometastatic disease in cancers of epithelial organs. Furthermore, in 2008 Dr. Eleftherios Georgakopoulos took over the management of the stem cell quality system of the Hygeia group.